US20050203595A1 - Ischemia laser treatment - Google Patents

Ischemia laser treatment Download PDF

Info

Publication number
US20050203595A1
US20050203595A1 US11/127,003 US12700305A US2005203595A1 US 20050203595 A1 US20050203595 A1 US 20050203595A1 US 12700305 A US12700305 A US 12700305A US 2005203595 A1 US2005203595 A1 US 2005203595A1
Authority
US
United States
Prior art keywords
laser
skull
cranium
brain
irradiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/127,003
Inventor
Amir Oron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Photothera Inc
Original Assignee
Photothera Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photothera Inc filed Critical Photothera Inc
Priority to US11/127,003 priority Critical patent/US20050203595A1/en
Publication of US20050203595A1 publication Critical patent/US20050203595A1/en
Assigned to ORON,URI reassignment ORON,URI ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ORON, AMIR
Assigned to PHOTOTHERA, INC. reassignment PHOTOTHERA, INC. LICENSE AGREEMENT INCLUDING ASSIGNMENT Assignors: ORON,URI
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0635Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0643Applicators, probes irradiating specific body areas in close proximity
    • A61N2005/0645Applicators worn by the patient
    • A61N2005/0647Applicators worn by the patient the applicator adapted to be worn on the head
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/067Radiation therapy using light using laser light

Definitions

  • Mammalian CNS neurons have a negligible capacity to regenerate following lesion or acute ischemic (no oxygen supply) conditions.
  • a dramatic decrease or complete abolishment of oxygen supply to the nerve cells and other cells in a certain region of the brain can occur due to occlusion of one or more of the arteries that supply blood to the brain (Fisher, M., “Characterizing the Target of Acute Stroke Therapy,” Stroke , Vol. 28, No. 4, pp. 866-872, April 1997).
  • the neurons of the brain go through a gradual degeneration process that eventually leads to necrosis in the acute ischemic zone.
  • Clinical syndromes such as paraplegia, quadriplegia, etc., are evident due to dysfunction of the nerve cells in the brain.
  • the mammalian CNS also has a negligible capacity to regenerate following injury. Limited regeneration of peripheral axons in mammals and CNS in lower vertebrate can take place in a post trauma setting.
  • Low energy laser irradiation has recently been found to modulate various processes in different biological systems (Belkin, et al., a critical review of low energy laser bioeffects, Lasers Light Ophthalmology , Vol. 2, p. 63-71, 1988, and Conlan, et al., biostimulation of wound healing by low energy laser irradiation, Journal of Clinical Periodontology , Vol. 23, p. 492-496, 1996).
  • the effect of low energy laser irradiation following trauma has been investigated so far in skin, peripheral nerves and skeletal muscles.
  • U.S. Pat. No. 5,580,555 to Schwartz involves the administration of tumor necrosis factor (TNF) to the sight of injury in the optic nerve in order to facilitate regeneration of axons across the sight of the injury.
  • TNF tumor necrosis factor
  • the use of low energy laser in conjunction with the use of the TNF is suggested to augment the effect of TNF.
  • Schwartz presents no experimental results to favor the beneficial effect of the laser. Furthermore, it is described in the detailed description that treatment with TNF alone (without laser irradiation) gives good results.
  • U.S. Pat. No. 4,966,144 to Rochkind, et al. deals with a method of inducing functional regeneration. of nerve fibers of an injured sight. of the. spinal cord (or using grafts of peripheral nerves which were placed into the injured sight) by a light source which generates light at a wavelength of 330-1200 nm.
  • the method involves only the spinal cord but not the brain.
  • the method is not related to an acute ischemic phase of nerve cells in the CNS as in a situation of “stroke” nor is the cytoprotective effect of laser irradiation cited in Rochkind , et al.
  • LEL irradiation allows cells under stressful conditions of low or no oxygen supply to maintain their viability in spite of the harsh conditions.
  • the irradiated cells most probably do not degenerate to the same extent as the non-irradiated cells and therefore also the inflammatory response, which is typical to tissues undergoing a degenerative process following injury, is markedly decreased.
  • LEL irradiation has been found to enhance the process of formation of new blood vessels (angiogenesis) in injured skeletal muscles (Bibikovu A. Belkin A. and Oron U. Enhancement of angiogenesis in regenerating gastrocnemius muscle of the toad ( Butfo Viridis ) by low energy laser irradiation. Anat. Embryol (1994), Vol. 190, pp. 597-602.).
  • the present invention seeks to provide a novel method and apparatus for using LEL irradiation to protect cells under acute ischemic conditions in the brain.
  • the LEL irradiation in the initial phase of ischemia, causes an enhanced angiogenesis process which in turn causes a regeneration process in the injured brain cells in the ischemic zone, thereby allowing for greater protection of the cells in the future.
  • apparatus for treatment of an. ischemic region of brain cells in a cranium including a skull covering adapted to cover at least part of a cranium, at least one guide attached to the skull covering, and a laser source which is operative to direct a laser beam through the at least one guide into a cranium.
  • the at least one guide may include an optic fiber or a waveguide.
  • the laser source includes a diode laser.
  • a laser controller is operatively connected to the laser source which controls operation of the laser source.
  • an actuator which is operative to move the laser source further from or closer to a cranium.
  • the skull covering includes sealing material at a skull-contacting periphery thereof.
  • a timer is mounted on the skull covering.
  • an indicator light is mounted on the skull covering.
  • a plurality of the guides are attached to the skull covering which direct a plurality of the laser beams in a plurality of directions.
  • a-plurality of the guides are attached to the skull covering which are operative to focus a plurality of the laser beams in a plurality of focal lengths into a cranium.
  • a plurality of the guides is commonly attached to the laser source.
  • each source directs a laser beam through one the guide.
  • FIG. 1 is a simplified pictorial illustration of apparatus for treatment of an ischemic region of brain cells in a cranium, constructed and operative in accordance with a preferred embodiment of the present invention
  • FIG. 2 is a simplified pictorial illustration of apparatus for treatment of an ischemic region of brain cells in a cranium, constructed and operative in accordance with another preferred embodiment of the present invention.
  • FIG. 3 is a simplified pictorial illustration of apparatus for treatment of an ischemic region of brain cells in a cranium, constructed and operative in accordance with yet another preferred embodiment of the present invention.
  • FIG. 1 illustrates apparatus 10 for treatment of an ischemic region of brain cells in a cranium, in accordance with a preferred embodiment of the present invention.
  • Apparatus 10 preferably includes a multiplicity of laser sources 12 , such as diode lasers, arranged for multidirectional multifocal irradiation of the cranium.
  • Laser sources 12 are mounted in a skull covering 14 , preferably constructed of metal, plastic or any other irradiation blocking material, and are preferably controlled by a laser controller 15 , either mounted externally or internally on skull covering 14 .
  • Each laser source 12 preferably delivers laser energy to the skull via a guide 16 , such as an optic fiber or waveguide.
  • Laser sources 12 are preferably connected to a servo system 18 which includes one or more actuators 20 which can move laser sources further from or closer to the cranium, thereby controlling the distance of the distal ends of guides 16 from the cranium.
  • Skull covering 14 may cover the entire skull including the brainstem, or alternatively, only part of the skull.
  • Apparatus 10 preferably includes one or more indicator lights 22 which provide various operational visual signals, such as malfunction warning signals, for example.
  • Skull covering 14 preferably has sealing material 24 at its skull-contacting periphery so as to prevent stray radiation from escaping.
  • Apparatus 10 preferably includes a timer 26 with an LCD to allow an operator to monitor the irradiation process in real time. Other safety options may be included.
  • FIG. 2 illustrates apparatus 30 for treatment of an ischemic region of brain cells in a cranium, in accordance with another preferred embodiment of the present invention.
  • Apparatus 30 is basically the same as apparatus 10 , with like numerals designating like elements, although not all elements are shown in FIG. 2 for the sake of simplicity.
  • Apparatus 30 differs from apparatus 10 in that apparatus 30 includes one laser source 12 and a multiplicity of guides 16 which are arranged for multidirectional multifocal irradiation of the cranium, as described above for apparatus 10 .
  • FIG. 3 illustrates apparatus 40 for treatment of an ischemic region of brain cells in a cranium, in accordance with yet another preferred embodiment of the present invention.
  • Apparatus 40 is basically the same as apparatus 10 or 30 , with like numerals designating like elements, although not all elements are shown in FIG. 3 for the sake of simplicity.
  • Apparatus 40 differs from apparatus 10 or 30 in that apparatus 40 also includes a heartbeat sensor probe 42 .
  • Guide 16 may be housed inside or outside of probe 42 , in accordance with the requirements of the particular application.
  • Apparatus 40 is particularly useful for treating newborn infants, as is now described.
  • a newborn may be subject to different kinds of stress-elated problems, one example being insufficient oxygen and blood supply to the brain which is a major cause of morbidity and mortality.
  • Factors contributing to brain damage and other adverse outcomes are complex. Both severe hypoxia-ischemia and prolonged hypoxia of lesser severity may cause brain damage (Low J A, Cerebral perfusion, metabolism and outcome; Curr Opin Pediatr: 7(2): pp. 132-9 April 1995).
  • hypoxia such as hypoxic-ischemic encephalopathy., cerebral palsy, microcephaly, seizure disorders, mental retardation, educational failure and others (Behrman, Kliegman, et al., Nelson's Textbook of Pediatrics, 15th Ed. W. B. Saunders Company: pp. 431-3; 1996).
  • Apparatus 40 is particularly useful for treating newborns, such as during exit from the vagina, wherein laser sources 12 can deliver laser energy to the: cranium of the newborn infant quickly and efficiently.
  • apparatus 40 may be fashioned without skull covering 14 , if desired.
  • skull coverings 14 of different sizes and shapes may be provided to a hospital or clinic for perinatal care.
  • Different energy delivery coefficients may be calculated for laser sources 12 depending upon the particular application. The position of the laser sources and the paths of the laser beams into the cranium are based on various factors, such as an anatomical consideration of the newborn (for example, the anatomy of the fontanels).
  • Apparatus 40 can be combined with conventional monitoring systems and with those under current development.
  • the technique of irradiating the brain with apparatus 40 may be used in conjunction with other methods for protecting the brain, such as the use of glutamate receptor antagonists, glucocorticoids, voltage sensitive calcium channel antagonists etc. (Tuor U I, Del Bigio . M R et al., Brain damage due to cerebral hypoxialischemia in. the neonate: pathology and pharmacological modification; Cerebrovasc Brain Metab Rev, 8(2): pp 159-93 Summer 1996).
  • the left common carotid artery of 12 mature Sprague-Dawley rats (250-300 gr. body weight anesthetized with Avertin) was exposed by a longitudinal incision to the frontal midline section of the neck. It was then occluded by ligation with a silk (4-0) thread.
  • the brains of six rats were irradiated by a diode laser.
  • the irradiation was performed by a longitudinal incision in the scalp to expose the skull.
  • the laser source (wavelength 807 millimicron, 400 mW maximal power output) was attached to the parietal bone in the skull (after exposing the skin) at two points: one between the eyes and one 1 cm posterior to the previous one. The duration of each irradiation was 2 minutes.
  • the dispersion of the laser beam after its passage through the skull was measured by an infrared viewer in a preliminary experiment.
  • the energy density that reached the brain tissue was 8 mW per square centimeter.
  • the other six rats had lasers attached to the skull but the lasers were not connected to an energy source.
  • Rats were followed up after surgery for various neurological disorders. All the rats that did not receive laser irradiation showed a prolapsed eyelid on the left side and minor motor neurological deficits at 12 hours post occlusion of the-left carotid artery.
  • Occlusion of the left coronary artery was performed on fifteen white mice (25-35 gr.) in a similar method to that described for rats in Experiment I.
  • mice Seven of the mice were irradiated with the same laser as in Experiment I. The irradiation was performed through the skin that covers the skull. The power output of the laser was set so that the brain of the mice was exposed to an energy of 5 mW/sq. cm. for 2 minutes.
  • mice served as control animals which went through the same process as the laser irradiated mice, but with the laser not turned on.
  • mice After induction of the stroke by ligation of the carotid artery, the mice were observed daily for neurological disorders/deficits and loss of weight. The results are presented in Table I.
  • the human skull can serve as a “natural lens” that disperses the laser beam so that a larger area of the brain will be laser irradiated.
  • the penetration of low energy laser through the human skull is a feasible option to deliver this energy to the brain cells if the external laser source is operated at the proper power output. This energy will cause a beneficial biostimulation on brain cells after stroke and other related disorders.

Abstract

Apparatus for treatment of an ischemic region of brain cells in a cranium, comprising a skull covering adapted to cover at least part of the cranium, at least one guide attached to the skull covering, and a laser source which is operative to direct a laser beam through the at least one guide into the cranium. The at least one guide may include an optic filiter or a waveguide.

Description

    RELATED APPLICATION INFORMATION
  • This application is a continuation of U.S. patent application Ser. No. 10/353,130 filed Jan. 28, 2003, which is a continuation of U.S. patent application Ser. No. 09/701,838, filed Apr. 12, 2001, now U.S. Pat. No. 6,537,304, issued Mar. 25, 2003, which is a national phase application under 35 U.S.C. § 371 of International Application No. PCT/IL99/00287 filed May 31, 1999, which claims the benefit of Israeli Patent No. 124722 filed Jun. 2, 1998.
  • FIELD OF THE INVENTION
  • Cytoprotective effect and increase of survival of neurons in the Central Nervous System (CNS) of mammals following ischemia (as in stroke), by low energy laser (LEL) irradiation.
  • BACKGROUND OF THE INVENTION
  • Mammalian CNS neurons have a negligible capacity to regenerate following lesion or acute ischemic (no oxygen supply) conditions. A dramatic decrease or complete abolishment of oxygen supply to the nerve cells and other cells in a certain region of the brain can occur due to occlusion of one or more of the arteries that supply blood to the brain (Fisher, M., “Characterizing the Target of Acute Stroke Therapy,” Stroke, Vol. 28, No. 4, pp. 866-872, April 1997). Concomitantly with this event, the neurons of the brain go through a gradual degeneration process that eventually leads to necrosis in the acute ischemic zone. Clinical syndromes such as paraplegia, quadriplegia, etc., are evident due to dysfunction of the nerve cells in the brain.
  • The mammalian CNS also has a negligible capacity to regenerate following injury. Limited regeneration of peripheral axons in mammals and CNS in lower vertebrate can take place in a post trauma setting.
  • Low energy laser irradiation has recently been found to modulate various processes in different biological systems (Belkin, et al., a critical review of low energy laser bioeffects, Lasers Light Ophthalmology, Vol. 2, p. 63-71, 1988, and Conlan, et al., biostimulation of wound healing by low energy laser irradiation, Journal of Clinical Periodontology, Vol. 23, p. 492-496, 1996). The effect of low energy laser irradiation following trauma has been investigated so far in skin, peripheral nerves and skeletal muscles.
  • Assia, et al. (temporal parameters of low energy laser irradiation for optimal delay of post traumatic degeneration of Ito rat optic nerve, Brain Research, 476: 205-212, 1989) described the possibility of delaying the post traumatic process of degeneration and scar tissue formation of a crushed optic never (peripheral nervous system) by low energy laser irradiation.
  • U.S. Pat. No. 5,580,555 to Schwartz involves the administration of tumor necrosis factor (TNF) to the sight of injury in the optic nerve in order to facilitate regeneration of axons across the sight of the injury. The use of low energy laser in conjunction with the use of the TNF is suggested to augment the effect of TNF. However, Schwartz presents no experimental results to favor the beneficial effect of the laser. Furthermore, it is described in the detailed description that treatment with TNF alone (without laser irradiation) gives good results.
  • It has previously been suggested that regeneration of injured peripheral nerves can-be accelerated by LEL (Rochkind S. Stimulation effect of laser energy on the regeneration of traumatically injured peripheral nerves. The Krim National Medical Inst., Morphogenesis and Regenerations, Vol. 73, pp. 48-50, 1978). .Nissan M. Rochkind S., et al. (HeNe laser irradiation delivered transcutaneously: its effect on sciatic nerve of rats. Laser. Surg. Med., Vol. 6, pp. 435-438, 1986) also demonstrated that transcutaneous LEL of sciatic nerve induced an increase in the amplitude of the electrical signals recorded in the irradiated nerve, i.e., increased the size of the action potential.
  • U.S. Pat. No. 4,966,144 to Rochkind, et al., deals with a method of inducing functional regeneration. of nerve fibers of an injured sight. of the. spinal cord (or using grafts of peripheral nerves which were placed into the injured sight) by a light source which generates light at a wavelength of 330-1200 nm. The method involves only the spinal cord but not the brain. Moreover, the method is not related to an acute ischemic phase of nerve cells in the CNS as in a situation of “stroke” nor is the cytoprotective effect of laser irradiation cited in Rochkind, et al.
  • It has previously been reported that the low energy laser irradiation causes a decrease in the inflammatory response following injury to skeletal muscles (Bibikova A. & U. Oron. Promotion of muscle regeneration following cold injury to the toad (Bufo Viridis) gastrocnemius muscle by low energy laser irradiation. Anat. Rec. (1993), Vol. 235, pp. 374-380 and N. Weiss & U. Oran Enhancement of muscle regeneration in the rat gastrocnemius muscle by low energy laser irradiation. Anat. Embryol. (1992), Vol. 186, pp. 497-503). The above phenomenon may suggest possible cytoprotective effect of at least the mitochondria and maybe other structures of the cell by the LEL. Thus, LEL irradiation allows cells under stressful conditions of low or no oxygen supply to maintain their viability in spite of the harsh conditions. The irradiated cells most probably do not degenerate to the same extent as the non-irradiated cells and therefore also the inflammatory response, which is typical to tissues undergoing a degenerative process following injury, is markedly decreased. Furthermore, LEL irradiation has been found to enhance the process of formation of new blood vessels (angiogenesis) in injured skeletal muscles (Bibikovu A. Belkin A. and Oron U. Enhancement of angiogenesis in regenerating gastrocnemius muscle of the toad (Butfo Viridis) by low energy laser irradiation. Anat. Embryol (1994), Vol. 190, pp. 597-602.).
  • So far, despite significant research efforts for many years worldwide, a safe and effective method of inhibiting or eliminating the adverse irreversible effects of stroke and other ischemic events on brain cells and the significant clinical manifestations of it on animal and human body function has yet to be developed.
  • SUMMARY OF THE INVENTION
  • The present invention seeks to provide a novel method and apparatus for using LEL irradiation to protect cells under acute ischemic conditions in the brain. In accordance with the present invention, in the initial phase of ischemia, the LEL irradiation causes an enhanced angiogenesis process which in turn causes a regeneration process in the injured brain cells in the ischemic zone, thereby allowing for greater protection of the cells in the future.
  • There is thus provided in accordance with a preferred embodiment of the present invention apparatus for treatment of an. ischemic region of brain cells in a cranium, including a skull covering adapted to cover at least part of a cranium, at least one guide attached to the skull covering, and a laser source which is operative to direct a laser beam through the at least one guide into a cranium. The at least one guide may include an optic fiber or a waveguide.
  • In accordance with a preferred embodiment of the present invention, the laser source includes a diode laser.
  • Further, in accordance with a preferred embodiment of the present invention, a laser controller is operatively connected to the laser source which controls operation of the laser source.
  • Still further in accordance with a preferred embodiment of the present invention, an actuator which is operative to move the laser source further from or closer to a cranium.
  • Additionally, in accordance with a preferred embodiment of the present invention, the skull covering includes sealing material at a skull-contacting periphery thereof.
  • In accordance with a preferred embodiment of the present invention, a timer is mounted on the skull covering.
  • Further in accordance with a preferred embodiment of the present invention, an indicator light is mounted on the skull covering.
  • Still further in accordance with a preferred embodiment of the present invention, a plurality of the guides are attached to the skull covering which direct a plurality of the laser beams in a plurality of directions.
  • Additionally in accordance with a preferred embodiment of the present invention, a-plurality of the guides are attached to the skull covering which are operative to focus a plurality of the laser beams in a plurality of focal lengths into a cranium.
  • In accordance with a preferred embodiment of the present invention, a plurality of the guides is commonly attached to the laser source.
  • Further in accordance with a preferred embodiment of the present invention, a plurality of the laser sources and a plurality of the guides are provided, wherein each source directs a laser beam through one the guide.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The present invention will be understood and appreciated more fully from the following detailed description, taken in conjunction with the drawings in which:
  • FIG. 1 is a simplified pictorial illustration of apparatus for treatment of an ischemic region of brain cells in a cranium, constructed and operative in accordance with a preferred embodiment of the present invention;
  • FIG. 2 is a simplified pictorial illustration of apparatus for treatment of an ischemic region of brain cells in a cranium, constructed and operative in accordance with another preferred embodiment of the present invention; and
  • FIG. 3 is a simplified pictorial illustration of apparatus for treatment of an ischemic region of brain cells in a cranium, constructed and operative in accordance with yet another preferred embodiment of the present invention.
  • DETAILED DESCRIPTION OF A PREFERRED EMBODIMENT
  • Reference is now made to FIG. 1 which illustrates apparatus 10 for treatment of an ischemic region of brain cells in a cranium, in accordance with a preferred embodiment of the present invention.
  • Apparatus 10 preferably includes a multiplicity of laser sources 12, such as diode lasers, arranged for multidirectional multifocal irradiation of the cranium. Laser sources 12 are mounted in a skull covering 14, preferably constructed of metal, plastic or any other irradiation blocking material, and are preferably controlled by a laser controller 15, either mounted externally or internally on skull covering 14. Each laser source 12 preferably delivers laser energy to the skull via a guide 16, such as an optic fiber or waveguide. Laser sources 12 are preferably connected to a servo system 18 which includes one or more actuators 20 which can move laser sources further from or closer to the cranium, thereby controlling the distance of the distal ends of guides 16 from the cranium.
  • Skull covering 14 may cover the entire skull including the brainstem, or alternatively, only part of the skull. Apparatus 10 preferably includes one or more indicator lights 22 which provide various operational visual signals, such as malfunction warning signals, for example. Skull covering 14 preferably has sealing material 24 at its skull-contacting periphery so as to prevent stray radiation from escaping. Apparatus 10 preferably includes a timer 26 with an LCD to allow an operator to monitor the irradiation process in real time. Other safety options may be included.
  • Reference is now made to FIG. 2 which illustrates apparatus 30 for treatment of an ischemic region of brain cells in a cranium, in accordance with another preferred embodiment of the present invention. Apparatus 30 is basically the same as apparatus 10, with like numerals designating like elements, although not all elements are shown in FIG. 2 for the sake of simplicity. Apparatus 30 differs from apparatus 10 in that apparatus 30 includes one laser source 12 and a multiplicity of guides 16 which are arranged for multidirectional multifocal irradiation of the cranium, as described above for apparatus 10.
  • Reference is now made to FIG. 3 which illustrates apparatus 40 for treatment of an ischemic region of brain cells in a cranium, in accordance with yet another preferred embodiment of the present invention. Apparatus 40 is basically the same as apparatus 10 or 30, with like numerals designating like elements, although not all elements are shown in FIG. 3 for the sake of simplicity. Apparatus 40 differs from apparatus 10 or 30 in that apparatus 40 also includes a heartbeat sensor probe 42. Guide 16 may be housed inside or outside of probe 42, in accordance with the requirements of the particular application. Apparatus 40 is particularly useful for treating newborn infants, as is now described.
  • During the process of birth, a newborn may be subject to different kinds of stress-elated problems, one example being insufficient oxygen and blood supply to the brain which is a major cause of morbidity and mortality. Factors contributing to brain damage and other adverse outcomes are complex. Both severe hypoxia-ischemia and prolonged hypoxia of lesser severity may cause brain damage (Low J A, Cerebral perfusion, metabolism and outcome; Curr Opin Pediatr: 7(2): pp. 132-9 April 1995). Many morbid conditions are associated with hypoxia such as hypoxic-ischemic encephalopathy., cerebral palsy, microcephaly, seizure disorders, mental retardation, educational failure and others (Behrman, Kliegman, et al., Nelson's Textbook of Pediatrics, 15th Ed. W. B. Saunders Company: pp. 431-3; 1996).
  • Apparatus 40 is particularly useful for treating newborns, such as during exit from the vagina, wherein laser sources 12 can deliver laser energy to the: cranium of the newborn infant quickly and efficiently. In such use for newborns, apparatus 40 may be fashioned without skull covering 14, if desired. Alternatively, an assortment of skull coverings 14 of different sizes and shapes may be provided to a hospital or clinic for perinatal care. Different energy delivery coefficients may be calculated for laser sources 12 depending upon the particular application. The position of the laser sources and the paths of the laser beams into the cranium are based on various factors, such as an anatomical consideration of the newborn (for example, the anatomy of the fontanels).
  • Apparatus 40 can be combined with conventional monitoring systems and with those under current development. The technique of irradiating the brain with apparatus 40 may be used in conjunction with other methods for protecting the brain, such as the use of glutamate receptor antagonists, glucocorticoids, voltage sensitive calcium channel antagonists etc. (Tuor U I, Del Bigio. M R et al., Brain damage due to cerebral hypoxialischemia in. the neonate: pathology and pharmacological modification; Cerebrovasc Brain Metab Rev, 8(2): pp 159-93 Summer 1996).
  • The invention was carried out using the above-described apparatus in two exemplary experiments which are now described.
  • Experiment I:
  • The left common carotid artery of 12 mature Sprague-Dawley rats (250-300 gr. body weight anesthetized with Avertin) was exposed by a longitudinal incision to the frontal midline section of the neck. It was then occluded by ligation with a silk (4-0) thread.
  • The brains of six rats were irradiated by a diode laser. The irradiation was performed by a longitudinal incision in the scalp to expose the skull. The laser source (wavelength 807 millimicron, 400 mW maximal power output) was attached to the parietal bone in the skull (after exposing the skin) at two points: one between the eyes and one 1 cm posterior to the previous one. The duration of each irradiation was 2 minutes. The dispersion of the laser beam after its passage through the skull was measured by an infrared viewer in a preliminary experiment. The energy density that reached the brain tissue was 8 mW per square centimeter. The other six rats had lasers attached to the skull but the lasers were not connected to an energy source.
  • Rats were followed up after surgery for various neurological disorders. All the rats that did not receive laser irradiation showed a prolapsed eyelid on the left side and minor motor neurological deficits at 12 hours post occlusion of the-left carotid artery.
  • The-six rats that were irradiated as above revealed the-following:
  • One had a prolapsed eyelid on the left side with no other symptoms. All other rats revealed neither eyelid prolapse nor any neurological deficits.
  • Experiment II:
  • Occlusion of the left coronary artery was performed on fifteen white mice (25-35 gr.) in a similar method to that described for rats in Experiment I.
  • Seven of the mice were irradiated with the same laser as in Experiment I. The irradiation was performed through the skin that covers the skull. The power output of the laser was set so that the brain of the mice was exposed to an energy of 5 mW/sq. cm. for 2 minutes.
  • Since the laser beam beyond the skull was dispersed to a diameter of approximately 1.5 cm, only one irradiation in the center of the parietal bone was performed. The irradiation covered the entire dorsal part of the brain.
  • The other 8 mice served as control animals which went through the same process as the laser irradiated mice, but with the laser not turned on.
  • After induction of the stroke by ligation of the carotid artery, the mice were observed daily for neurological disorders/deficits and loss of weight. The results are presented in Table I.
  • It can be seen from Table I that neurological deficits such as prolapse of the left eyelid and paresis of hind legs (which was also evident by difficulty in locomotion) was significantly higher in the control non-irradiated mice. Furthermore, in 7 out of the 8 non-irradiated mice examined, the ligation of the left carotid artery resulted in up to 50% loss of weight and eventual death. In none of the laser irradiated mice was there a massive weight loss nor did any of them die due to the ligation of the left carotid artery.
  • It is therefore concluded that laser irradiation most probably has a protective effect on the nerve cells of the CNS or some other protective effect on the CNS as a whole unit. This effect inhibited adverse consequences that usually led to death in this experimental model. It may be postulated that the same protective effect may also be beneficial in the case of stroke or other ischemic events in the CNS of humans.
    TABLE I
    Effect of Laser Irradiation on Mice Post Ligation of
    the Left Common Carotid Artery.
    Death up to
    10 days post Paresis in Prolapse of Significant loss
    Treatment ligation. hind legs. left eyelid. of weight.
    Control 7/8 6/8 6/8 7/8
    (non irradiated)
    Laser irradiated 0/7 0/7 1/7 0/7
  • In addition to the above experiments, penetration of low energy laser irradiation through a human skull was studied using a fresh human skull. A Ga—As diode laser was applied (800 mW maximal output) and a laser meter was placed in the inner side of the skull cavity in order to detect the energy power and dispersion (using a laser infrared viewer) of the laser after penetration through the skull. The beam diameter of the laser was dispersed from 2 mm externally to the skull to 3.5 cm in the skull cavity after penetration through the skull wall in the parietal region of the skull (a width of about 8 mm). The energy density measured inside the skull cavity was 3 mW/sq.cm. In the squamosal region (side region) of the human skull, the width of the skull is about 5 mm; so it can be expected that penetration of the laser energy should be better.
  • The above study shows that the human skull can serve as a “natural lens” that disperses the laser beam so that a larger area of the brain will be laser irradiated. The penetration of low energy laser through the human skull is a feasible option to deliver this energy to the brain cells if the external laser source is operated at the proper power output. This energy will cause a beneficial biostimulation on brain cells after stroke and other related disorders.
  • It will be appreciated by persons skilled in the art that the present invention is not limited by what has been particularly shown and described hereinabove. Rather the scope of the present invention includes both combinations and subcombinations of the features described hereinabove as well as modifications and variations thereof which would occur to a person of skill in the art upon reading the foregoing description and which are not in the prior art.

Claims (2)

1. Apparatus for treatment of an ischemic region of brain cells in a cranium, comprising:
a skull covering adapted to cover at least part of a cranium;
at least one guide attached to said skull covering; and
a laser source which is operative to direct a laser beam through said at least one guide into a cranium.
2-13. (canceled)
US11/127,003 1998-06-02 2005-05-11 Ischemia laser treatment Abandoned US20050203595A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/127,003 US20050203595A1 (en) 1998-06-02 2005-05-11 Ischemia laser treatment

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IL124722 1998-06-02
IL12472298A IL124722A0 (en) 1998-06-02 1998-06-02 Ischemia laser treatment
PCT/IL1999/000287 WO1999062599A1 (en) 1998-06-02 1999-05-31 Ischemia laser treatment
US09/701,838 US6537304B1 (en) 1998-06-02 1999-05-31 Ischemia laser treatment
US10/353,130 US6918922B2 (en) 1998-06-02 2003-01-28 Ischemia laser treatment
US11/127,003 US20050203595A1 (en) 1998-06-02 2005-05-11 Ischemia laser treatment

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/353,130 Continuation US6918922B2 (en) 1998-06-02 2003-01-28 Ischemia laser treatment

Publications (1)

Publication Number Publication Date
US20050203595A1 true US20050203595A1 (en) 2005-09-15

Family

ID=11071582

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/701,838 Expired - Lifetime US6537304B1 (en) 1998-06-02 1999-05-31 Ischemia laser treatment
US10/353,130 Expired - Lifetime US6918922B2 (en) 1998-06-02 2003-01-28 Ischemia laser treatment
US11/127,003 Abandoned US20050203595A1 (en) 1998-06-02 2005-05-11 Ischemia laser treatment

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US09/701,838 Expired - Lifetime US6537304B1 (en) 1998-06-02 1999-05-31 Ischemia laser treatment
US10/353,130 Expired - Lifetime US6918922B2 (en) 1998-06-02 2003-01-28 Ischemia laser treatment

Country Status (4)

Country Link
US (3) US6537304B1 (en)
AU (1) AU4056699A (en)
IL (1) IL124722A0 (en)
WO (1) WO1999062599A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040138727A1 (en) * 2001-11-01 2004-07-15 Taboada Luis De Device and method for providing phototheraphy to the brain
US20040153130A1 (en) * 2002-05-29 2004-08-05 Amir Oron Methods for treating muscular dystrophy
US20060223155A1 (en) * 2002-11-01 2006-10-05 Jackson Streeter Enhancement of in vitro culture or vaccine production in bioreactors using electromagnetic energy
US20080221211A1 (en) * 2007-02-02 2008-09-11 Jackson Streeter Method of treatment of neurological injury or cancer by administration of dichloroacetate
US7848035B2 (en) 2008-09-18 2010-12-07 Photothera, Inc. Single-use lens assembly
US8025687B2 (en) 2003-01-24 2011-09-27 Photothera, Inc. Low level light therapy for enhancement of neurologic function
US20110238138A1 (en) * 2010-03-26 2011-09-29 Kosaku Takada Hair growth device
US8308784B2 (en) 2006-08-24 2012-11-13 Jackson Streeter Low level light therapy for enhancement of neurologic function of a patient affected by Parkinson's disease
RU2495688C1 (en) * 2012-03-28 2013-10-20 Государственное бюджетное учреждение здравоохранения Центр организации специализированной медицинской помощи "Челябинский государственный институт лазерной хирургии" Method of treating cerebral ischemia in experiment
US9993659B2 (en) 2001-11-01 2018-06-12 Pthera, Llc Low level light therapy for enhancement of neurologic function by altering axonal transport rate
US10188872B2 (en) 2006-01-30 2019-01-29 Pthera LLC Light-emitting device and method for providing phototherapy to the brain
US10357662B2 (en) 2009-02-19 2019-07-23 Pthera LLC Apparatus and method for irradiating a surface with light
US10683494B2 (en) 2001-11-01 2020-06-16 Pthera LLC Enhanced stem cell therapy and stem cell production through the administration of low level light energy
US10695577B2 (en) 2001-12-21 2020-06-30 Photothera, Inc. Device and method for providing phototherapy to the heart
US11273319B2 (en) 2008-03-18 2022-03-15 Pthera LLC Method and apparatus for irradiating a surface with pulsed light

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL124722A0 (en) 1998-06-02 1999-01-26 Oron Amir Ischemia laser treatment
WO2000035534A1 (en) * 1998-12-12 2000-06-22 Virulite Limited Electromagnetic radiation therapy
DE20115555U1 (en) * 2001-09-21 2002-01-10 Weber Michael Device for attaching at least one laser needle to the body of a patient
US20030109906A1 (en) * 2001-11-01 2003-06-12 Jackson Streeter Low level light therapy for the treatment of stroke
US20040082940A1 (en) * 2002-10-22 2004-04-29 Michael Black Dermatological apparatus and method
US20030144712A1 (en) * 2001-12-20 2003-07-31 Jackson Streeter, M.D. Methods for overcoming organ transplant rejection
US7316922B2 (en) * 2002-01-09 2008-01-08 Photothera Inc. Method for preserving organs for transplant
US20040132002A1 (en) * 2002-09-17 2004-07-08 Jackson Streeter Methods for preserving blood
US20040082074A1 (en) * 2002-10-11 2004-04-29 Mcgrath Terrence S. Axial atomic model for determination of elemental particle field structure and energy levels
US7284987B2 (en) * 2002-10-11 2007-10-23 Mcgrath Terrence S Physical quantum model for the atom
US7344555B2 (en) 2003-04-07 2008-03-18 The United States Of America As Represented By The Department Of Health And Human Services Light promotes regeneration and functional recovery after spinal cord injury
WO2006024038A2 (en) * 2004-08-27 2006-03-02 Codman & Shurtleff Light-based implant for treating alzheimer’s disease
US7722656B1 (en) * 2005-02-25 2010-05-25 Kim Robin Segal Device and method for stimulating hair growth
USRE47266E1 (en) 2005-03-14 2019-03-05 DePuy Synthes Products, Inc. Light-based implants for treating Alzheimer's disease
US7288108B2 (en) * 2005-03-14 2007-10-30 Codman & Shurtleff, Inc. Red light implant for treating Parkinson's disease
US7351253B2 (en) * 2005-06-16 2008-04-01 Codman & Shurtleff, Inc. Intranasal red light probe for treating Alzheimer's disease
US8262713B2 (en) 2005-09-26 2012-09-11 Depuy Spine, Inc. Red light implant for treating osteoporosis
US7465313B2 (en) * 2005-09-26 2008-12-16 Depuy Spine, Inc. Red light implant for treating degenerative disc disease
US8167920B2 (en) * 2005-10-31 2012-05-01 Codman & Shurtleff, Inc. Intranasal delivery of compounds that reduce intrancranial pressure
US7559945B2 (en) 2006-01-13 2009-07-14 Clarimedix Inc. Multi-spectral photon therapy device and methods of use
US10695579B2 (en) 2006-01-30 2020-06-30 Pthera LLC Apparatus and method for indicating treatment site locations for phototherapy to the brain
US20070179570A1 (en) * 2006-01-30 2007-08-02 Luis De Taboada Wearable device and method for providing phototherapy to the brain
US20080033412A1 (en) * 2006-08-01 2008-02-07 Harry Thomas Whelan System and method for convergent light therapy having controllable dosimetry
CN101795634A (en) * 2007-04-23 2010-08-04 透皮帽公司 Phototherapy light cap
WO2008136958A1 (en) * 2007-04-30 2008-11-13 Opthera, Inc. Uva1-led phototherapy device and method
US8236036B1 (en) 2007-07-21 2012-08-07 Frost Ricky A Optical dermatological and medical treatment apparatus having replaceable laser diodes
US20090054955A1 (en) * 2007-08-20 2009-02-26 Kopell Brian H Systems and Methods for Treating Neurological Disorders by Light Stimulation
US8249696B2 (en) * 2007-12-19 2012-08-21 Depuy Spine, Inc. Smart pedicle tool
US9180308B1 (en) 2008-01-18 2015-11-10 Ricky A. Frost Laser device for intracranial illumination via oral or nasal foramina access
US9320914B2 (en) 2008-03-03 2016-04-26 DePuy Synthes Products, Inc. Endoscopic delivery of red/NIR light to the subventricular zone
EP3431138B1 (en) * 2008-04-30 2024-01-24 Implantica Patent Ltd. Brain stimulation
US20100198316A1 (en) * 2009-02-04 2010-08-05 Richard Toselli Intracranial Red Light Treatment Device For Chronic Pain
US10071261B2 (en) 2009-05-01 2018-09-11 Wayne State University Light therapy treatment
WO2010127249A1 (en) 2009-05-01 2010-11-04 Wayne State University Light therapy treatment
US20110040356A1 (en) 2009-08-12 2011-02-17 Fredric Schiffer Methods for Treating Psychiatric Disorders Using Light Energy
WO2011146777A2 (en) 2010-05-19 2011-11-24 Photothera, Inc. Device and method for providing a synergistic combination of phototherapy and a non-light energy modality to the brain
FR3024355A1 (en) 2014-07-30 2016-02-05 Jean Tien EQUIPMENT FOR THE APPLICATION OF ACTIVE ELEMENTS ON THE SKULL OF A PATIENT
CN107072821B (en) 2014-09-09 2022-07-01 卢米希拉公司 Multi-wavelength phototherapy devices, systems, and methods for non-invasive treatment of damaged or diseased tissue
US11123366B1 (en) 2014-12-15 2021-09-21 Children's Hospital Of Orange County Methods, materials, and systems for treating injuries to the central nervous system using light emitting nanoparticles
US10569097B2 (en) 2015-07-28 2020-02-25 Photonmd, Inc. Systems and methods for phototherapeutic modulation of nitric oxide
EP3851162A1 (en) 2015-07-28 2021-07-21 KNOW Bio, LLC Phototherapy devices for treatment of dermatological disorders of the scalp
US10350429B2 (en) * 2016-02-08 2019-07-16 Ricky A. Frost Laser device for intracranial illumination via oral or nasal foramina access
US11167148B2 (en) 2016-02-26 2021-11-09 Cimphoni Life Sciences LLC Light emitting bone implants
US10780296B2 (en) 2017-09-01 2020-09-22 Reni-Zoe Zivin Transcranial laser therapy for treatment of acute ischemic stroke
US11147984B2 (en) 2020-03-19 2021-10-19 Know Bio, Llc Illumination devices for inducing biological effects
US11717698B1 (en) 2020-04-23 2023-08-08 Hugh McGrath, Jr. Therapy, treatment, and process for photodynamic inactivation of COVID-19
US11654294B2 (en) 2021-03-15 2023-05-23 Know Bio, Llc Intranasal illumination devices

Citations (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3107608A (en) * 1962-05-18 1963-10-22 Flynn & Emrich Company Two position ink roll bearing socket
US3375755A (en) * 1965-10-19 1968-04-02 James A. Hunt Control device for automating sequential machine operation
US3810367A (en) * 1970-07-16 1974-05-14 W Peterson Container for cooling, storage, and shipping of human organ for transplant
US4315514A (en) * 1980-05-08 1982-02-16 William Drewes Method and apparatus for selective cell destruction
US4343301A (en) * 1979-10-04 1982-08-10 Robert Indech Subcutaneous neural stimulation or local tissue destruction
US4633872A (en) * 1983-11-08 1987-01-06 Hgm, Incorporated Laser optical delivery apparatus
US4669466A (en) * 1985-01-16 1987-06-02 Lri L.P. Method and apparatus for analysis and correction of abnormal refractive errors of the eye
US4798215A (en) * 1984-03-15 1989-01-17 Bsd Medical Corporation Hyperthermia apparatus
US4846196A (en) * 1986-01-29 1989-07-11 Wiksell Hans O T Method and device for the hyperthermic treatment of tumors
US4930504A (en) * 1987-11-13 1990-06-05 Diamantopoulos Costas A Device for biostimulation of tissue and method for treatment of tissue
US4951653A (en) * 1988-03-02 1990-08-28 Laboratory Equipment, Corp. Ultrasound brain lesioning system
US4951482A (en) * 1988-12-21 1990-08-28 Gilbert Gary L Hypothermic organ transport apparatus
US4966144A (en) * 1987-06-09 1990-10-30 Simeone Rochkind Method for inducing regeneration of injured nerve fibers
US5029581A (en) * 1986-11-19 1991-07-09 Fuji Electric Co., Ltd. Laser therapeutic apparatus
US5037374A (en) * 1989-11-29 1991-08-06 Carol Mark P Stereotactic-guided radiation therapy system with variable-length compensating collimator
US5054470A (en) * 1988-03-02 1991-10-08 Laboratory Equipment, Corp. Ultrasonic treatment transducer with pressurized acoustic coupling
US5150704A (en) * 1986-06-23 1992-09-29 Fuji Electric Co., Ltd. Laser therapeutic apparatus
US5259380A (en) * 1987-11-04 1993-11-09 Amcor Electronics, Ltd. Light therapy system
US5267294A (en) * 1992-04-22 1993-11-30 Hitachi Medical Corporation Radiotherapy apparatus
US5282797A (en) * 1989-05-30 1994-02-01 Cyrus Chess Method for treating cutaneous vascular lesions
US5358503A (en) * 1994-01-25 1994-10-25 Bertwell Dale E Photo-thermal therapeutic device and method
US5368555A (en) * 1992-12-29 1994-11-29 Hepatix, Inc. Organ support system
US5401270A (en) * 1990-12-19 1995-03-28 Carl-Zeiss-Stiftung Applicator device for laser radiation
US5441495A (en) * 1989-08-17 1995-08-15 Life Resonances, Inc. Electromagnetic treatment therapy for stroke victim
US5445608A (en) * 1993-08-16 1995-08-29 James C. Chen Method and apparatus for providing light-activated therapy
US5445146A (en) * 1995-03-31 1995-08-29 Bellinger; Gary J. Biological tissue stimulation by low level optical energy
US5464436A (en) * 1994-04-28 1995-11-07 Lasermedics, Inc. Method of performing laser therapy
US5501655A (en) * 1992-03-31 1996-03-26 Massachusetts Institute Of Technology Apparatus and method for acoustic heat generation and hyperthermia
US5511563A (en) * 1991-06-21 1996-04-30 Diamond; Donald A. Apparatus and method for treating rheumatoid and psoriatic arthritis
US5540737A (en) * 1991-06-26 1996-07-30 Massachusetts Institute Of Technology Minimally invasive monopole phased array hyperthermia applicators and method for treating breast carcinomas
US5601526A (en) * 1991-12-20 1997-02-11 Technomed Medical Systems Ultrasound therapy apparatus delivering ultrasound waves having thermal and cavitation effects
US5616140A (en) * 1994-03-21 1997-04-01 Prescott; Marvin Method and apparatus for therapeutic laser treatment
US5621091A (en) * 1986-07-25 1997-04-15 The Children's Medical Center Corporation Probes for and nucleic acid encoding the muscular dystrophy protein, dystrophin
US5622168A (en) * 1992-11-18 1997-04-22 John L. Essmyer Conductive hydrogels and physiological electrodes and electrode assemblies therefrom
US5627870A (en) * 1993-06-07 1997-05-06 Atea, Societe Atlantique De Techniques Avancees Device for treating cerebral lesions by gamma radiation, and corresponding treatment apparatus
US5640978A (en) * 1991-11-06 1997-06-24 Diolase Corporation Method for pain relief using low power laser light
US5643334A (en) * 1995-02-07 1997-07-01 Esc Medical Systems Ltd. Method and apparatus for the diagnostic and composite pulsed heating and photodynamic therapy treatment
US5728090A (en) * 1995-02-09 1998-03-17 Quantum Devices, Inc. Apparatus for irradiating living cells
US5755752A (en) * 1992-04-24 1998-05-26 Segal; Kim Robin Diode laser irradiation system for biological tissue stimulation
US5817008A (en) * 1996-10-31 1998-10-06 Spacelabs Medical, Inc. Conformal pulse oximetry sensor and monitor
US5879376A (en) * 1995-07-12 1999-03-09 Luxar Corporation Method and apparatus for dermatology treatment
US5902741A (en) * 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
US5928207A (en) * 1997-06-30 1999-07-27 The Regents Of The University Of California Microneedle with isotropically etched tip, and method of fabricating such a device
US5928945A (en) * 1996-11-20 1999-07-27 Advanced Tissue Sciences, Inc. Application of shear flow stress to chondrocytes or chondrocyte stem cells to produce cartilage
US5954762A (en) * 1997-09-15 1999-09-21 Di Mino; Alfonso Computer-controlled servo-mechanism for positioning corona discharge beam applicator
US5983141A (en) * 1996-06-27 1999-11-09 Radionics, Inc. Method and apparatus for altering neural tissue function
US5989245A (en) * 1994-03-21 1999-11-23 Prescott; Marvin A. Method and apparatus for therapeutic laser treatment
US6042531A (en) * 1995-06-19 2000-03-28 Holcomb; Robert R. Electromagnetic therapeutic treatment device and methods of using same
US6046046A (en) * 1997-09-23 2000-04-04 Hassanein; Waleed H. Compositions, methods and devices for maintaining an organ
US6045575A (en) * 1997-09-10 2000-04-04 Amt, Inc. Therapeutic method and internally illuminated garment for the management of disorders treatable by phototherapy
US6060306A (en) * 1995-06-07 2000-05-09 Advanced Tissue Sciences, Inc. Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing replacement cartilage tissue constructs
US6063108A (en) * 1997-01-06 2000-05-16 Salansky; Norman Method and apparatus for localized low energy photon therapy (LEPT)
US6107325A (en) * 1995-01-17 2000-08-22 Qlt Phototherapeutics, Inc. Green porphyrins as immunomodulators
US6112110A (en) * 1997-01-07 2000-08-29 Wilk; Peter J. Medical treatment system with scanner input
US6117128A (en) * 1997-04-30 2000-09-12 Kenton W. Gregory Energy delivery catheter and method for the use thereof
US6129748A (en) * 1996-03-22 2000-10-10 Kamei; Tsutomu Apparatus for applying pulsed light to the forehead of a user
US6143878A (en) * 1994-11-29 2000-11-07 The University Of Queensland Sox-9 gene and protein and use in the regeneration of bone or cartilage
US6146410A (en) * 1995-11-24 2000-11-14 Nagypal; Tibor Apparatus for the photodynamic treatment of living beings or organs thereof
US6149679A (en) * 1997-09-15 2000-11-21 Adm Tronics Ulimited, Inc. Corona discharge beam treatment of neuro-cerebral disorders
US6179771B1 (en) * 1998-04-21 2001-01-30 Siemens Aktiengesellschaft Coil arrangement for transcranial magnetic stimulation
US6198958B1 (en) * 1998-06-11 2001-03-06 Beth Israel Deaconess Medical Center, Inc. Method and apparatus for monitoring a magnetic resonance image during transcranial magnetic stimulation
US6210317B1 (en) * 1998-07-13 2001-04-03 Dean R. Bonlie Treatment using oriented unidirectional DC magnetic field
US6214035B1 (en) * 1999-03-23 2001-04-10 Jackson Streeter Method for improving cardiac microcirculation
US6221095B1 (en) * 1996-11-13 2001-04-24 Meditech International Inc. Method and apparatus for photon therapy
US6277974B1 (en) * 1999-12-14 2001-08-21 Cogent Neuroscience, Inc. Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
US6290713B1 (en) * 1999-08-24 2001-09-18 Thomas A. Russell Flexible illuminators for phototherapy
US20010044623A1 (en) * 1998-12-21 2001-11-22 Light Sciences Corporation Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue
US6358272B1 (en) * 1995-05-16 2002-03-19 Lutz Wilden Therapy apparatus with laser irradiation device
US6363285B1 (en) * 2000-01-21 2002-03-26 Albert C. Wey Therapeutic sleeping aid device
US6364907B1 (en) * 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
US6379295B1 (en) * 1997-09-26 2002-04-30 Gilson Woo Treatment of afflictions, ailments and diseases
US6395016B1 (en) * 1996-07-28 2002-05-28 Biosense, Inc. Method of treating a heart using cells irradiated in vitro with biostimulatory irradiation
US6397107B1 (en) * 1998-04-27 2002-05-28 Bokwang Co., Ltd. Apparatus for embolic treatment using high frequency induction heating
US20020068927A1 (en) * 2000-06-27 2002-06-06 Prescott Marvin A. Method and apparatus for myocardial laser treatment
US6402678B1 (en) * 2000-07-31 2002-06-11 Neuralieve, Inc. Means and method for the treatment of migraine headaches
US20020087205A1 (en) * 1999-01-15 2002-07-04 Light Sciences Corporation Transcutaneous photodynamic treatment of targeted cells
US6421562B1 (en) * 2000-07-17 2002-07-16 Jesse Ross Alternative treatment of a nonsurgically treatable intracranial occlusion
US6443978B1 (en) * 1998-04-10 2002-09-03 Board Of Trustees Of The University Of Arkansas Photomatrix device
US20020123781A1 (en) * 2001-03-02 2002-09-05 Shanks Steven C. Therapeutic laser device
US6471716B1 (en) * 2000-07-11 2002-10-29 Joseph P. Pecukonis Low level light therapy method and apparatus with improved wavelength, temperature and voltage control
US6514220B2 (en) * 2001-01-25 2003-02-04 Walnut Technologies Non focussed method of exciting and controlling acoustic fields in animal body parts
US6537304B1 (en) * 1998-06-02 2003-03-25 Amir Oron Ischemia laser treatment
US6551308B1 (en) * 1997-09-17 2003-04-22 Laser-Und Medizin-Technologie Gmbh Berlin Laser therapy assembly for muscular tissue revascularization
US20030125782A1 (en) * 2001-11-15 2003-07-03 Jackson Streeter Methods for the regeneration of bone and cartilage
US20030144712A1 (en) * 2001-12-20 2003-07-31 Jackson Streeter, M.D. Methods for overcoming organ transplant rejection
US20030167080A1 (en) * 2002-03-04 2003-09-04 Hart Barry Michael Joint / tissue inflammation therapy and monitoring device(s) JITMon device
US20040014199A1 (en) * 2002-01-09 2004-01-22 Jackson Streeter Method for preserving organs for transplant
US20040044384A1 (en) * 2002-09-03 2004-03-04 Leber Leland C. Therapeutic method and apparatus
US20040132002A1 (en) * 2002-09-17 2004-07-08 Jackson Streeter Methods for preserving blood
US20050009161A1 (en) * 2002-11-01 2005-01-13 Jackson Streeter Enhancement of in vitro culture or vaccine production using electromagnetic energy treatment
US20050107851A1 (en) * 2002-11-01 2005-05-19 Taboada Luis D. Device and method for providing phototherapy to the brain

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5844784A (en) * 1981-09-11 1983-03-15 Nippon Sekigaisen Kogyo Kk Laser device
IT1171078B (en) * 1983-07-04 1987-06-10 Adriano Tessiore ELECTROMECHANICAL IRRADIANT EQUIPMENT, FOR THE TREATMENT OF HAIR LEATHER, AGAINST Baldness
DE3686621T2 (en) * 1985-07-31 1993-02-25 Bard Inc C R INFRARED LASER CATHETER DEVICE.
IE911318A1 (en) 1990-04-23 1991-10-23 Yeda Res & Dev Use of a tumor necrosis factor for facilitating nerve¹regeneration
JPH0423634A (en) 1990-05-18 1992-01-28 Mitsubishi Electric Corp Line error rate monitor device
GB9208653D0 (en) 1992-04-22 1992-06-10 Unilever Plc Cosmetic composition and process for making it
US6156028A (en) * 1994-03-21 2000-12-05 Prescott; Marvin A. Method and apparatus for therapeutic laser treatment of wounds
US5849585A (en) * 1995-05-10 1998-12-15 Genetech, Inc. Isolating and culturing Schwann cells
JP2002511774A (en) 1996-07-28 2002-04-16 バイオセンス・インコーポレイテッド Electromagnetic heart biostimulation
US6107608A (en) * 1997-03-24 2000-08-22 Micron Technology, Inc. Temperature controlled spin chuck
CA2364501A1 (en) 1998-02-23 1999-08-26 Philip W. Passy Therapeutic cluster laser device
US6663659B2 (en) * 2000-01-13 2003-12-16 Mcdaniel David H. Method and apparatus for the photomodulation of living cells
US6602275B1 (en) * 2000-09-18 2003-08-05 Jana Sullivan Device and method for therapeutic treatment of living organisms

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3107608A (en) * 1962-05-18 1963-10-22 Flynn & Emrich Company Two position ink roll bearing socket
US3375755A (en) * 1965-10-19 1968-04-02 James A. Hunt Control device for automating sequential machine operation
US3810367A (en) * 1970-07-16 1974-05-14 W Peterson Container for cooling, storage, and shipping of human organ for transplant
US4343301A (en) * 1979-10-04 1982-08-10 Robert Indech Subcutaneous neural stimulation or local tissue destruction
US4315514A (en) * 1980-05-08 1982-02-16 William Drewes Method and apparatus for selective cell destruction
US4633872A (en) * 1983-11-08 1987-01-06 Hgm, Incorporated Laser optical delivery apparatus
US4798215A (en) * 1984-03-15 1989-01-17 Bsd Medical Corporation Hyperthermia apparatus
US4669466A (en) * 1985-01-16 1987-06-02 Lri L.P. Method and apparatus for analysis and correction of abnormal refractive errors of the eye
US4846196A (en) * 1986-01-29 1989-07-11 Wiksell Hans O T Method and device for the hyperthermic treatment of tumors
US5902741A (en) * 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
US5150704A (en) * 1986-06-23 1992-09-29 Fuji Electric Co., Ltd. Laser therapeutic apparatus
US5621091A (en) * 1986-07-25 1997-04-15 The Children's Medical Center Corporation Probes for and nucleic acid encoding the muscular dystrophy protein, dystrophin
US5029581A (en) * 1986-11-19 1991-07-09 Fuji Electric Co., Ltd. Laser therapeutic apparatus
US4966144A (en) * 1987-06-09 1990-10-30 Simeone Rochkind Method for inducing regeneration of injured nerve fibers
US5259380A (en) * 1987-11-04 1993-11-09 Amcor Electronics, Ltd. Light therapy system
US4930504A (en) * 1987-11-13 1990-06-05 Diamantopoulos Costas A Device for biostimulation of tissue and method for treatment of tissue
US4951653A (en) * 1988-03-02 1990-08-28 Laboratory Equipment, Corp. Ultrasound brain lesioning system
US5054470A (en) * 1988-03-02 1991-10-08 Laboratory Equipment, Corp. Ultrasonic treatment transducer with pressurized acoustic coupling
US4951482A (en) * 1988-12-21 1990-08-28 Gilbert Gary L Hypothermic organ transport apparatus
US5282797A (en) * 1989-05-30 1994-02-01 Cyrus Chess Method for treating cutaneous vascular lesions
US5441495A (en) * 1989-08-17 1995-08-15 Life Resonances, Inc. Electromagnetic treatment therapy for stroke victim
US5037374A (en) * 1989-11-29 1991-08-06 Carol Mark P Stereotactic-guided radiation therapy system with variable-length compensating collimator
US5401270A (en) * 1990-12-19 1995-03-28 Carl-Zeiss-Stiftung Applicator device for laser radiation
US5511563A (en) * 1991-06-21 1996-04-30 Diamond; Donald A. Apparatus and method for treating rheumatoid and psoriatic arthritis
US5540737A (en) * 1991-06-26 1996-07-30 Massachusetts Institute Of Technology Minimally invasive monopole phased array hyperthermia applicators and method for treating breast carcinomas
US5640978A (en) * 1991-11-06 1997-06-24 Diolase Corporation Method for pain relief using low power laser light
US5601526A (en) * 1991-12-20 1997-02-11 Technomed Medical Systems Ultrasound therapy apparatus delivering ultrasound waves having thermal and cavitation effects
US5501655A (en) * 1992-03-31 1996-03-26 Massachusetts Institute Of Technology Apparatus and method for acoustic heat generation and hyperthermia
US5267294A (en) * 1992-04-22 1993-11-30 Hitachi Medical Corporation Radiotherapy apparatus
US5755752A (en) * 1992-04-24 1998-05-26 Segal; Kim Robin Diode laser irradiation system for biological tissue stimulation
US6033431A (en) * 1992-04-24 2000-03-07 Segal; Kim Robin Diode laser irradiation system for biological tissue stimulation
US5622168A (en) * 1992-11-18 1997-04-22 John L. Essmyer Conductive hydrogels and physiological electrodes and electrode assemblies therefrom
US5368555A (en) * 1992-12-29 1994-11-29 Hepatix, Inc. Organ support system
US5627870A (en) * 1993-06-07 1997-05-06 Atea, Societe Atlantique De Techniques Avancees Device for treating cerebral lesions by gamma radiation, and corresponding treatment apparatus
US5445608A (en) * 1993-08-16 1995-08-29 James C. Chen Method and apparatus for providing light-activated therapy
US5358503A (en) * 1994-01-25 1994-10-25 Bertwell Dale E Photo-thermal therapeutic device and method
US5989245A (en) * 1994-03-21 1999-11-23 Prescott; Marvin A. Method and apparatus for therapeutic laser treatment
US5616140A (en) * 1994-03-21 1997-04-01 Prescott; Marvin Method and apparatus for therapeutic laser treatment
US5464436A (en) * 1994-04-28 1995-11-07 Lasermedics, Inc. Method of performing laser therapy
US6143878A (en) * 1994-11-29 2000-11-07 The University Of Queensland Sox-9 gene and protein and use in the regeneration of bone or cartilage
US6107325A (en) * 1995-01-17 2000-08-22 Qlt Phototherapeutics, Inc. Green porphyrins as immunomodulators
US5643334A (en) * 1995-02-07 1997-07-01 Esc Medical Systems Ltd. Method and apparatus for the diagnostic and composite pulsed heating and photodynamic therapy treatment
US5728090A (en) * 1995-02-09 1998-03-17 Quantum Devices, Inc. Apparatus for irradiating living cells
US5445146A (en) * 1995-03-31 1995-08-29 Bellinger; Gary J. Biological tissue stimulation by low level optical energy
US6358272B1 (en) * 1995-05-16 2002-03-19 Lutz Wilden Therapy apparatus with laser irradiation device
US6060306A (en) * 1995-06-07 2000-05-09 Advanced Tissue Sciences, Inc. Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing replacement cartilage tissue constructs
US6042531A (en) * 1995-06-19 2000-03-28 Holcomb; Robert R. Electromagnetic therapeutic treatment device and methods of using same
US5879376A (en) * 1995-07-12 1999-03-09 Luxar Corporation Method and apparatus for dermatology treatment
US6146410A (en) * 1995-11-24 2000-11-14 Nagypal; Tibor Apparatus for the photodynamic treatment of living beings or organs thereof
US6129748A (en) * 1996-03-22 2000-10-10 Kamei; Tsutomu Apparatus for applying pulsed light to the forehead of a user
US5983141A (en) * 1996-06-27 1999-11-09 Radionics, Inc. Method and apparatus for altering neural tissue function
US6395016B1 (en) * 1996-07-28 2002-05-28 Biosense, Inc. Method of treating a heart using cells irradiated in vitro with biostimulatory irradiation
US6443974B1 (en) * 1996-07-28 2002-09-03 Biosense, Inc. Electromagnetic cardiac biostimulation
US5817008A (en) * 1996-10-31 1998-10-06 Spacelabs Medical, Inc. Conformal pulse oximetry sensor and monitor
US6221095B1 (en) * 1996-11-13 2001-04-24 Meditech International Inc. Method and apparatus for photon therapy
US5928945A (en) * 1996-11-20 1999-07-27 Advanced Tissue Sciences, Inc. Application of shear flow stress to chondrocytes or chondrocyte stem cells to produce cartilage
US6063108A (en) * 1997-01-06 2000-05-16 Salansky; Norman Method and apparatus for localized low energy photon therapy (LEPT)
US6112110A (en) * 1997-01-07 2000-08-29 Wilk; Peter J. Medical treatment system with scanner input
US6117128A (en) * 1997-04-30 2000-09-12 Kenton W. Gregory Energy delivery catheter and method for the use thereof
US5928207A (en) * 1997-06-30 1999-07-27 The Regents Of The University Of California Microneedle with isotropically etched tip, and method of fabricating such a device
US6187210B1 (en) * 1997-06-30 2001-02-13 The Regents Of The University Of California Epidermal abrasion device with isotropically etched tips, and method of fabricating such a device
US6045575A (en) * 1997-09-10 2000-04-04 Amt, Inc. Therapeutic method and internally illuminated garment for the management of disorders treatable by phototherapy
US5954762A (en) * 1997-09-15 1999-09-21 Di Mino; Alfonso Computer-controlled servo-mechanism for positioning corona discharge beam applicator
US6149679A (en) * 1997-09-15 2000-11-21 Adm Tronics Ulimited, Inc. Corona discharge beam treatment of neuro-cerebral disorders
US6551308B1 (en) * 1997-09-17 2003-04-22 Laser-Und Medizin-Technologie Gmbh Berlin Laser therapy assembly for muscular tissue revascularization
US6046046A (en) * 1997-09-23 2000-04-04 Hassanein; Waleed H. Compositions, methods and devices for maintaining an organ
US6379295B1 (en) * 1997-09-26 2002-04-30 Gilson Woo Treatment of afflictions, ailments and diseases
US6443978B1 (en) * 1998-04-10 2002-09-03 Board Of Trustees Of The University Of Arkansas Photomatrix device
US6179771B1 (en) * 1998-04-21 2001-01-30 Siemens Aktiengesellschaft Coil arrangement for transcranial magnetic stimulation
US6397107B1 (en) * 1998-04-27 2002-05-28 Bokwang Co., Ltd. Apparatus for embolic treatment using high frequency induction heating
US6537304B1 (en) * 1998-06-02 2003-03-25 Amir Oron Ischemia laser treatment
US6198958B1 (en) * 1998-06-11 2001-03-06 Beth Israel Deaconess Medical Center, Inc. Method and apparatus for monitoring a magnetic resonance image during transcranial magnetic stimulation
US6210317B1 (en) * 1998-07-13 2001-04-03 Dean R. Bonlie Treatment using oriented unidirectional DC magnetic field
US6364907B1 (en) * 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
US20010044623A1 (en) * 1998-12-21 2001-11-22 Light Sciences Corporation Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue
US6344050B1 (en) * 1998-12-21 2002-02-05 Light Sciences Corporation Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue
US20020087205A1 (en) * 1999-01-15 2002-07-04 Light Sciences Corporation Transcutaneous photodynamic treatment of targeted cells
US6267780B1 (en) * 1999-03-23 2001-07-31 Jackson Streeter Method for treating musculoskeletal injury
US6312451B1 (en) * 1999-03-23 2001-11-06 Jackson Streeter Low level laser therapy apparatus
US6290714B1 (en) * 1999-03-23 2001-09-18 Jackson Streeter Method for treating bone fracture
US6214035B1 (en) * 1999-03-23 2001-04-10 Jackson Streeter Method for improving cardiac microcirculation
US6273905B1 (en) * 1999-03-23 2001-08-14 Jackson Streeter Method for treating spinal cord transection
US6290713B1 (en) * 1999-08-24 2001-09-18 Thomas A. Russell Flexible illuminators for phototherapy
US6277974B1 (en) * 1999-12-14 2001-08-21 Cogent Neuroscience, Inc. Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
US6363285B1 (en) * 2000-01-21 2002-03-26 Albert C. Wey Therapeutic sleeping aid device
US20020068927A1 (en) * 2000-06-27 2002-06-06 Prescott Marvin A. Method and apparatus for myocardial laser treatment
US6471716B1 (en) * 2000-07-11 2002-10-29 Joseph P. Pecukonis Low level light therapy method and apparatus with improved wavelength, temperature and voltage control
US6421562B1 (en) * 2000-07-17 2002-07-16 Jesse Ross Alternative treatment of a nonsurgically treatable intracranial occlusion
US6402678B1 (en) * 2000-07-31 2002-06-11 Neuralieve, Inc. Means and method for the treatment of migraine headaches
US6514220B2 (en) * 2001-01-25 2003-02-04 Walnut Technologies Non focussed method of exciting and controlling acoustic fields in animal body parts
US20020123781A1 (en) * 2001-03-02 2002-09-05 Shanks Steven C. Therapeutic laser device
US20030125782A1 (en) * 2001-11-15 2003-07-03 Jackson Streeter Methods for the regeneration of bone and cartilage
US20030144712A1 (en) * 2001-12-20 2003-07-31 Jackson Streeter, M.D. Methods for overcoming organ transplant rejection
US20040014199A1 (en) * 2002-01-09 2004-01-22 Jackson Streeter Method for preserving organs for transplant
US20030167080A1 (en) * 2002-03-04 2003-09-04 Hart Barry Michael Joint / tissue inflammation therapy and monitoring device(s) JITMon device
US20040044384A1 (en) * 2002-09-03 2004-03-04 Leber Leland C. Therapeutic method and apparatus
US20040132002A1 (en) * 2002-09-17 2004-07-08 Jackson Streeter Methods for preserving blood
US20050009161A1 (en) * 2002-11-01 2005-01-13 Jackson Streeter Enhancement of in vitro culture or vaccine production using electromagnetic energy treatment
US20050107851A1 (en) * 2002-11-01 2005-05-19 Taboada Luis D. Device and method for providing phototherapy to the brain

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10758743B2 (en) 2001-11-01 2020-09-01 Pthera LLC Method for providing phototherapy to the brain
US9993659B2 (en) 2001-11-01 2018-06-12 Pthera, Llc Low level light therapy for enhancement of neurologic function by altering axonal transport rate
US10683494B2 (en) 2001-11-01 2020-06-16 Pthera LLC Enhanced stem cell therapy and stem cell production through the administration of low level light energy
US20040138727A1 (en) * 2001-11-01 2004-07-15 Taboada Luis De Device and method for providing phototheraphy to the brain
US20100094384A1 (en) * 2001-11-01 2010-04-15 Luis De Taboada System and method for providing phototherapy to the brain
US10913943B2 (en) 2001-11-01 2021-02-09 Pthera LLC Enhanced stem cell therapy and stem cell production through the administration of low level light energy
US10695577B2 (en) 2001-12-21 2020-06-30 Photothera, Inc. Device and method for providing phototherapy to the heart
US20040153130A1 (en) * 2002-05-29 2004-08-05 Amir Oron Methods for treating muscular dystrophy
US20060223155A1 (en) * 2002-11-01 2006-10-05 Jackson Streeter Enhancement of in vitro culture or vaccine production in bioreactors using electromagnetic energy
US7309348B2 (en) * 2003-01-24 2007-12-18 Photothera, Inc. Method for treatment of depression
US8025687B2 (en) 2003-01-24 2011-09-27 Photothera, Inc. Low level light therapy for enhancement of neurologic function
US8167921B2 (en) 2003-01-24 2012-05-01 Jackson Streeter Low level light therapy for enhancement of neurologic function
US9795803B2 (en) 2003-01-24 2017-10-24 Pthera LLC Low level light therapy for enhancement of neurologic function
US20050187595A1 (en) * 2003-01-24 2005-08-25 Jackson Streeter Method for treatment of depression
US11179572B2 (en) 2006-01-30 2021-11-23 Pthera LLC Light-emitting device and method for providing phototherapy to the brain
US10188872B2 (en) 2006-01-30 2019-01-29 Pthera LLC Light-emitting device and method for providing phototherapy to the brain
US8308784B2 (en) 2006-08-24 2012-11-13 Jackson Streeter Low level light therapy for enhancement of neurologic function of a patient affected by Parkinson's disease
US20080221211A1 (en) * 2007-02-02 2008-09-11 Jackson Streeter Method of treatment of neurological injury or cancer by administration of dichloroacetate
US11273319B2 (en) 2008-03-18 2022-03-15 Pthera LLC Method and apparatus for irradiating a surface with pulsed light
US10071259B2 (en) 2008-09-18 2018-09-11 Pthera, Llc Optical assembly
US8149526B2 (en) 2008-09-18 2012-04-03 Photothera, Inc. Single use lens assembly
US7848035B2 (en) 2008-09-18 2010-12-07 Photothera, Inc. Single-use lens assembly
US10357662B2 (en) 2009-02-19 2019-07-23 Pthera LLC Apparatus and method for irradiating a surface with light
US11219782B2 (en) 2009-02-19 2022-01-11 Pthera LLC Apparatus and method for irradiating a surface with light
US20110238138A1 (en) * 2010-03-26 2011-09-29 Kosaku Takada Hair growth device
RU2495688C1 (en) * 2012-03-28 2013-10-20 Государственное бюджетное учреждение здравоохранения Центр организации специализированной медицинской помощи "Челябинский государственный институт лазерной хирургии" Method of treating cerebral ischemia in experiment

Also Published As

Publication number Publication date
US20030216797A1 (en) 2003-11-20
WO1999062599A1 (en) 1999-12-09
AU4056699A (en) 1999-12-20
US6918922B2 (en) 2005-07-19
US6537304B1 (en) 2003-03-25
IL124722A0 (en) 1999-01-26

Similar Documents

Publication Publication Date Title
US6537304B1 (en) Ischemia laser treatment
Hamblin Shining light on the head: photobiomodulation for brain disorders
Hamblin Photobiomodulation for traumatic brain injury and stroke
Naeser et al. Potential for transcranial laser or LED therapy to treat stroke, traumatic brain injury, and neurodegenerative disease
US9610460B2 (en) Light therapy treatment
US20210252302A1 (en) Light therapy treatment
US9649507B2 (en) Low level laser therapy for Alzheimer's disease
Johnstone et al. The potential of light therapy in Parkinson's disease
Rosner et al. Dose and temporal parameters in delaying injured optic nerve degeneration by low‐energy laser irradiation
Belkin et al. Evidence for the existence of low-energy laser bioeffects on the nervous system
US11724123B2 (en) Photobiomodulation therapy to treat a degenerative condition of the retina and/or the optic nerve
Lim The potential of treating alzheimer’s disease with intranasal light therapy
KR20160039928A (en) Device for Alopecia-healing using laser
Hamblin et al. Low-level light therapy aids traumatic brain injury
Belkin et al. Ophthalmic effects of low-energy laser irradiation
Xunbin et al. Phototherapy of Neurodegenerative Diseases: Mechanism, Application, and Prospect
Magkouti et al. Quantitative EEG as outcome measure of the therapeutic effects of transcranial pho-tobiomodulation: a systematic review
Caldieraro et al. Transcranial and systemic photobiomodulation for the enhancement of mitochondrial metabolism in depression
Zadorozhnyy et al. Photobiomodulation therapy in ophthalmology
Castel et al. Low energy laser biostimulation: New prospects for medical applications
Naser et al. Transcranial Photobiomodulation (tPBM) Therapy In Brain Disorders
Koski Emerging treatments
Schwartz et al. Low-energy laser irradiation: a possible neuroprotective modality
Johnstone The potential of light therapy in Parkinson’s
Hamblin MA, 02114, USA.

Legal Events

Date Code Title Description
AS Assignment

Owner name: PHOTOTHERA, INC., CALIFORNIA

Free format text: LICENSE AGREEMENT INCLUDING ASSIGNMENT;ASSIGNOR:ORON,URI;REEL/FRAME:018989/0232

Effective date: 20021001

Owner name: ORON,URI, ISRAEL

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ORON, AMIR;REEL/FRAME:018989/0227

Effective date: 20021001

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION